Remdesivir is part of SOC.
Our s/c was not Leronlimab vs placebo (sugar water)
It was Leronlimab vs everything they can throw at s/c patients.
Remdesivir, plasma, steroids, on and on.

Remdesivir is approved for s/c covid-19 patients.
Leronlimab reduces death in critical 24% bertter than Remdesivir.
FDA will issue EUA, but when.
Shorts and bashers will try to make the trial look unsuccessful.

The longhauler market is substantial and LL will probably be the preferred drug
eventually, but not the only drug.